相关实验视频

Updated: May 11, 2025

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

监管T细胞疗法用于移植对宿主疾病

Memnon Lysandrou^1,2, Dionysia Kefala¹, Janaki Manoja Vinnakota²

¹Bone Marrow Transplantation Unit and Institute of Cell Therapy, University of Patras, Patras, Greece.

Bone marrow transplantation

|April 16, 2025

概括

调控性T细胞 (Treg) 是一种有希望的替代常规免疫抑制,用于在异构造血细胞移植 (allo-HCT) 后预防移植与宿主疾病 (GvHD). 这种方法旨在恢复免疫耐受性,同时保持移植对抗白血病 (GvL) 效应.

科学领域:

免疫学免疫学免疫学
移植医学移植医学
细胞疗法细胞疗法

背景情况:

移植对宿主疾病 (GvHD) 是异构造血细胞移植 (allo-HCT) 后的一个主要并发症,导致显著的发病率和死亡率.
目前用于GvHD的免疫抑制疗法存在局限性,特别是在耐火病例中,并且可能会损害有益的移植对抗白血病 (GvL) 效应.

研究的目的:

审查关于调控性T细胞 (Treg) 生物学的当前知识.
探索不同Treg亚型在管理GvHD.的临床应用.
讨论以Treg为基础的allo-HCT免疫疗法的未来方向.

主要方法:

关于Treg生物学和临床研究的文献综述.
对Treg亚型及其在GvHD预防和治疗中的有效性进行分析.
讨论Treg疗法的挑战和未来前景.

主要成果:

调节性T细胞 (Tregs) 显示出在合HCT后恢复免疫耐受性的潜力.
特雷格疗法可以规避长期免疫抑制的需要.
保护移植对抗白血病 (GvL) 效应是基于Treg的方法的一个关键优势.

结论:

使用Tregs的采用免疫疗法代表了GvHD常规免疫抑制的有希望的替代方案.
对Treg生物学和临床应用的进一步研究对于优化alo-HCT结果至关重要.
特雷格疗法具有改善GvHD管理的潜力,同时保持抗白血病活性.

更多相关视频

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Published on: August 20, 2007

相关概念视频

Cell-mediated Immune Responses

Cell-mediated Immune Responses

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.